Could intratumoural microbiota be key to unlocking treatment responses in hepatocellular carcinoma?
Authors:
Open Access
- 21 December 2024
- journal article
- review article
- Published by Elsevier in European Journal of Cancer
- Vol. 216, 115195
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Intratumoural microbiome can predict the prognosis of hepatocellular carcinoma after surgeryClinical and Translational Medicine, 2023
- Awareness of intratumoral bacteria and their potential application in cancer treatmentDiscover Oncology, 2023
- Survival of primary liver cancer for people from culturally and linguistically diverse backgrounds in AustraliaCancer Epidemiology, 2022
- Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCCHepatology, 2022
- Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinomaHepatology International, 2022
- Intratumoral Microbiome of Human Primary Liver CancerHepatology Communications, 2022
- The intratumoral microbiome: Characterization methods and functional impactCancer Letters, 2021
- Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2020
- Potential applications and emerging trends of species of the genus Dietzia: a reviewAnnals of Microbiology, 2013
- Inhibitory effects of canthaxanthin on in vitro growth of murine tumor cellsCancer Letters, 1992